These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19995369)

  • 1. T-plastin (PLS3) gene expression differentiates Sézary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression.
    Tang N; Gibson H; Germeroth T; Porcu P; Lim HW; Wong HK
    Br J Dermatol; 2010 Feb; 162(2):463-6. PubMed ID: 19995369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible expression and pathophysiologic functions of T-plastin in cutaneous T-cell lymphoma.
    Bégué E; Jean-Louis F; Bagot M; Jauliac S; Cayuela JM; Laroche L; Parquet N; Bachelez H; Bensussan A; Courtois G; Michel L
    Blood; 2012 Jul; 120(1):143-54. PubMed ID: 22627769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome.
    Rittig AH; Lindahl LM; Johansen C; Celis P; Ødum N; Iversen L; Litman T
    Acta Derm Venereol; 2019 Nov; 99(12):1148-1153. PubMed ID: 31453630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Expression of PLS3 Correlates with Better Outcome in Sézary Syndrome.
    Boonk SE; Zoutman WH; Putter H; Ram-Wolff C; Felcht M; Klemke CD; Ranki A; Quaglino P; Whittaker S; Bagot M; Willemze R; Vermeer MH
    J Invest Dermatol; 2017 Mar; 137(3):754-757. PubMed ID: 27984038
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis.
    Michel L; Jean-Louis F; Begue E; Bensussan A; Bagot M
    Blood; 2013 Feb; 121(8):1477-8. PubMed ID: 23429988
    [No Abstract]   [Full Text] [Related]  

  • 6. Three-Dimensional Telomeric Fingerprint of Mycosis Fungoides and/or Sézary Syndrome: A Pilot Study.
    Bienz MN; Petrogiannis-Haliotis T; Pehr K; Benlimame N; Mai S; Knecht H
    J Invest Dermatol; 2021 Jun; 141(6):1598-1601.e4. PubMed ID: 33212153
    [No Abstract]   [Full Text] [Related]  

  • 7. Allelotyping in mycosis fungoides and Sézary syndrome: common regions of allelic loss identified on 9p, 10q, and 17p.
    Scarisbrick JJ; Woolford AJ; Russell-Jones R; Whittaker SJ
    J Invest Dermatol; 2001 Sep; 117(3):663-70. PubMed ID: 11564174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new molecular paradigm in mycosis fungoides and Sézary syndrome.
    Elenitoba-Johnson KS; Wilcox R
    Semin Diagn Pathol; 2017 Jan; 34(1):15-21. PubMed ID: 28024703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma.
    Jones CL; Ferreira S; McKenzie RC; Tosi I; Caesar JA; Bagot M; Whittaker SJ; Mitchell TJ
    J Invest Dermatol; 2012 Aug; 132(8):2042-9. PubMed ID: 22495182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycosis fungoides and the Sézary syndrome.
    Gisselbrecht C; Dubertret L
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):73-5. PubMed ID: 8511044
    [No Abstract]   [Full Text] [Related]  

  • 11. TMEM244 Gene Expression as a Potential Blood Diagnostic Marker Distinguishing Sézary Syndrome from Mycosis Fungoides and Benign Erythroderma.
    Rassek K; Iżykowska K; Żurawek M; Nowicka K; Joks M; Olek-Hrab K; Olszewska B; Sokołowska-Wojdyło M; Biernat W; Nowicki RJ; Przybylski GK
    J Invest Dermatol; 2023 Feb; 143(2):344-347.e3. PubMed ID: 36087622
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma.
    LeBlanc RE; Lefterova MI; Suarez CJ; Tavallaee M; Kim YH; Schrijver I; Kim J; Gratzinger D
    Hum Pathol; 2015 Sep; 46(9):1382-9. PubMed ID: 26193796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
    Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular pathogenesis of mycosis fungoides and Sézary syndrome.
    Döbbeling U
    G Ital Dermatol Venereol; 2008 Dec; 143(6):385-94. PubMed ID: 19169211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of p16 tumor suppressor gene inactivation in mycosis fungoides and Sézary syndrome and role of the bmi-1 and ras oncogenes in disease progression.
    Zhang C; Toulev A; Kamarashev J; Qin JZ; Dummer R; Döbbeling U
    Hum Pathol; 2007 Jul; 38(7):995-1002. PubMed ID: 17442375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome.
    Whittaker SJ; Smith NP; Jones RR; Luzzatto L
    Cancer; 1991 Oct; 68(7):1572-82. PubMed ID: 1654197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKp46-specific expression on skin-resident CD4(+) lymphocytes in mycosis fungoides and Sézary syndrome.
    Schneider P; Plassa LF; Ratajczak P; Leboeuf C; Verneuil L; Battistella M; Bensussan A; Bagot M; Janin A
    J Invest Dermatol; 2014 Feb; 134(2):574-578. PubMed ID: 23900021
    [No Abstract]   [Full Text] [Related]  

  • 18. Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2.
    Ungewickell A; Bhaduri A; Rios E; Reuter J; Lee CS; Mah A; Zehnder A; Ohgami R; Kulkarni S; Armstrong R; Weng WK; Gratzinger D; Tavallaee M; Rook A; Snyder M; Kim Y; Khavari PA
    Nat Genet; 2015 Sep; 47(9):1056-60. PubMed ID: 26258847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycosis fungoides and Sézary syndrome.
    Hwang ST; Janik JE; Jaffe ES; Wilson WH
    Lancet; 2008 Mar; 371(9616):945-57. PubMed ID: 18342689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
    Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.